Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

CTLA4-Ig: a novel immunosuppressive agent.

CTLA4-Ig: a novel immunosuppressive agent. Expert Opin Investig Drugs. 2000 Sep; 9(9):2147-57.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.